drugset / Trial / NCT07456878

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

NCT07456878

Phase 1 Recruiting 5 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this research is to evaluate the diagnostic role and clinical efficacy of investigational FET-PET/MRI in detecting MRI-occult primary or residual/recurrent functional pituitary adenomas (PAs) and its influence on clinical and surgical decisions.

Timeline

Start
2026-01-08
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FET Diagnostic / imaging agent 185 mbq Intravenous